* Trinity Biotech PLC TRIB.OQ TRIB.O is expected to show
a
fall in quarterly revenue when it reports results on April 11
(estimated).
* The Bray Wicklow-based company is expected to report a
26.8% decrease in revenue to $24 million from $32.77 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Trinity Biotech PLC
is
for earnings of 7 cents per share. For the same quarter last
year, the company reported earnings of 36 cents per share.
* The one available analyst rating on the shares is "strong
buy".
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "Strong Buy".
* Wall Street's median 12-month price target for Trinity
Biotech
PLC is $4, above its last closing price of $1.00.
This summary was machine generated April 8 at 11:03 GMT. All
figures in US dollars unless otherwise stated